STRYKER CORP
SYKNYSELatest results at a glance
Insights from the latest company results and reports · filed 30 Jul 2026
Segment Performance Highlights
MedSurg and Neurotechnology net sales reached $3.6 billion, up 9.7% year-over-year. Orthopaedics net sales totaled $3.0 billion, increasing 9.1% in the quarter.
Narrowed Full-Year Guidance
The company narrowed its full-year 2026 guidance, expecting organic net sales growth between 8.3% and 9.3%. Adjusted net earnings per diluted share are guided to a range of $14.95 to $15.10.
Margin Expansion and Cash Flow
Reported gross profit margin was 68.3% and operating income margin was 25.2% in the quarter.
Company research evidence
Checked financial measurements with the values, reporting periods and measurement basis shown together. This evidence is available independently of the AI report.
Loading evidence…
Deep Dive Research
Source-linked company research for SYK
Revenue segmentation
Loading segment disclosures…